Does increased CCL2-mediated immune cell recruitment during mucosal BCG vaccination provide superior protection against TB?
作者信息
Serpa Gregory, Hemann Emily A, Long Matthew E
机构信息
Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA; Department of Microbial Infection and Immunity, The Ohio State University Wexner Medical Center, Columbus, OH, USA; Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Department of Microbial Infection and Immunity, The Ohio State University Wexner Medical Center, Columbus, OH, USA; Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
出版信息
Mol Ther. 2024 Nov 6;32(11):3763-3764. doi: 10.1016/j.ymthe.2024.10.009. Epub 2024 Oct 28.
Abstract
摘要
相似文献
1
Does increased CCL2-mediated immune cell recruitment during mucosal BCG vaccination provide superior protection against TB?在黏膜卡介苗接种期间，CCL2介导的免疫细胞募集增加是否能提供更好的结核病防护？
Mol Ther. 2024 Nov 6;32(11):3763-3764. doi: 10.1016/j.ymthe.2024.10.009. Epub 2024 Oct 28.
2
Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis.黏膜卡介苗接种可诱导针对结核病的具有保护性的肺驻留记忆T细胞群体。
mBio. 2016 Nov 22;7(6):e01686-16. doi: 10.1128/mBio.01686-16.
3
Intranasal vaccination with engineered BCG expressing CCL2 induces a stronger immune barrier against Mycobacterium tuberculosis than BCG.鼻内接种表达 CCL2 的工程化卡介苗比卡介苗诱导更强的针对结核分枝杆菌的免疫屏障。
Mol Ther. 2024 Nov 6;32(11):3990-4005. doi: 10.1016/j.ymthe.2024.09.021. Epub 2024 Sep 18.
4
Distal airway epithelial progenitors mediate TGF-β release to drive lung CD8 T induction following mucosal BCG vaccination.远端气道上皮祖细胞介导转化生长因子-β释放，以驱动黏膜卡介苗接种后肺部CD8 T细胞的诱导。
Mucosal Immunol. 2025 Aug;18(4):973-988. doi: 10.1016/j.mucimm.2025.05.007. Epub 2025 May 30.
5
AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates.AdHu5Ag85A呼吸道黏膜加强免疫增强卡介苗初免非人灵长类动物对肺结核的保护作用。
PLoS One. 2015 Aug 7;10(8):e0135009. doi: 10.1371/journal.pone.0135009. eCollection 2015.
6
Sendai Virus Mucosal Vaccination Establishes Lung-Resident Memory CD8 T Cell Immunity and Boosts BCG-Primed Protection against TB in Mice.仙台病毒黏膜疫苗接种可建立肺部驻留记忆性CD8 T细胞免疫，并增强卡介苗引发的对小鼠结核病的保护作用。
Mol Ther. 2017 May 3;25(5):1222-1233. doi: 10.1016/j.ymthe.2017.02.018. Epub 2017 Mar 23.
7
Mucosal delivery of ESX-1-expressing BCG strains provides superior immunity against tuberculosis in murine type 2 diabetes.ESX-1 表达的卡介苗菌株经黏膜递送可提供针对 2 型糖尿病小鼠结核病的优异免疫力。
Proc Natl Acad Sci U S A. 2020 Aug 25;117(34):20848-20859. doi: 10.1073/pnas.2003235117. Epub 2020 Aug 10.
8
Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis.用基于重组腺病毒的疫苗进行单次黏膜免疫而非肠胃外免疫，可提供针对肺结核的有效保护。
J Immunol. 2004 Nov 15;173(10):6357-65. doi: 10.4049/jimmunol.173.10.6357.
9
Intravenous BCG vaccination in non-human primates induces superior serum antibody titers with enhanced avidity and opsonizing capacity compared to the intradermal route.与皮内途径相比，在非人类灵长类动物中进行静脉注射卡介苗可诱导产生更高的血清抗体滴度，且亲和力和调理能力增强。
Vaccine. 2024 Dec 2;42(26):126444. doi: 10.1016/j.vaccine.2024.126444. Epub 2024 Nov 10.
10
Protection against tuberculosis by Bacillus Calmette-Guérin (BCG) vaccination: A historical perspective.卡介苗（BCG）接种预防结核病：历史视角。
Med. 2022 Jan 14;3(1):6-24. doi: 10.1016/j.medj.2021.11.006. Epub 2021 Dec 31.
本文引用的文献
1
Intranasal vaccination with engineered BCG expressing CCL2 induces a stronger immune barrier against Mycobacterium tuberculosis than BCG.鼻内接种表达 CCL2 的工程化卡介苗比卡介苗诱导更强的针对结核分枝杆菌的免疫屏障。
Mol Ther. 2024 Nov 6;32(11):3990-4005. doi: 10.1016/j.ymthe.2024.09.021. Epub 2024 Sep 18.
2
A century of BCG vaccination: Immune mechanisms, animal models, non-traditional routes and implications for COVID-19.一个世纪的卡介苗接种：免疫机制、动物模型、非传统途径及其对 COVID-19 的影响。
Front Immunol. 2022 Aug 26;13:959656. doi: 10.3389/fimmu.2022.959656. eCollection 2022.
3
Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis.婴儿卡介苗（BCG）接种与全生命周期肺部和肺外结核发病风险：系统评价和个体参与者数据荟萃分析。
Lancet Glob Health. 2022 Sep;10(9):e1307-e1316. doi: 10.1016/S2214-109X(22)00283-2.
4
Recombinant BCG to Enhance Its Immunomodulatory Activities.重组卡介苗以增强其免疫调节活性。
Vaccines (Basel). 2022 May 23;10(5):827. doi: 10.3390/vaccines10050827.
5
The Diverse Applications of Recombinant BCG-Based Vaccines to Target Infectious Diseases Other Than Tuberculosis: An Overview.基于重组卡介苗的疫苗在结核病以外的其他传染病防治中的多样应用：综述
Front Microbiol. 2021 Oct 21;12:757858. doi: 10.3389/fmicb.2021.757858. eCollection 2021.
6
Mucosal vaccines - fortifying the frontiers.黏膜疫苗——强化前沿。
Nat Rev Immunol. 2022 Apr;22(4):236-250. doi: 10.1038/s41577-021-00583-2. Epub 2021 Jul 26.
7
Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination.黏膜 BCG 或 MTBVAC 疫苗接种比标准皮内疫苗接种更能增强训练有素的免疫。
Cell Rep Med. 2021 Jan 19;2(1):100185. doi: 10.1016/j.xcrm.2020.100185.
8
Manipulation of BCG vaccine: a double-edged sword.卡介苗的操作：一把双刃剑。
Eur J Clin Microbiol Infect Dis. 2016 Apr;35(4):535-43. doi: 10.1007/s10096-016-2579-y. Epub 2016 Jan 25.
9
Improved protection by recombinant BCG.重组卡介苗提供的增强保护作用。
Microbes Infect. 2005 May;7(5-6):939-46. doi: 10.1016/j.micinf.2005.03.012. Epub 2005 Apr 15.
Zotero 插件